996 research outputs found
Editorial Catalysts: Supported Metal Catalysts and Their Applications in Fine Chemicals
Editorial to the Special" Issue Supported Metal Catalysts and Their Applications in Fine Chemicals
Life cycle assessment of a polymer electrolyte membrane fuel cell system for passenger vehicles
In moving towards a more sustainable society, hydrogen fueled polymer electrolyte membrane (PEM) fuel cell technology is seen as a great opportunity to reduce the environmental impact of the transport sector. However, decision makers have the challenge of understanding the real environmental consequences of producing fuel cell vehicles (FCVs) compared to alternative green cars, such as battery electric vehicles (BEVs).
and more conventional internal combustion engine vehicles (ICEVs). In this work, we presented a comprehensive life cycle assessment (LCA) of a FCV focused on its manufacturing phase and compared with the production of a BEV and an ICEV. For the manufacturing phase, the FCV inventories started from the catalyst layer to the glider, including the hydrogen tank. A sensitivity analysis on some of the key components of the fuel cell stack and the FC system (such as balance-of-plant and hydrogen tank) was carried out to account for different assumptions on materials and inventory models. The production process of the fuel cell vehicle showed a higher environmental impact compared to the production of the other two vehicles power sources. This is mainly due to the hydrogen tank and the fuel cell stack. However, by combining the results of the sensitivity analysis for each component - a best-case scenario showed that there is the potential for a 25% reduction in the climate change impact category for the FCV compared to a baseline FCV scenario. Reducing the environmental impact associated with the manufacture of fuel cell vehicles represents an important challenge. The entire life cycle has also been considered and the manufacturing, use and disposal of FCV, electric vehicle and conventional diesel vehicle were compared. Overall, the ICEV showed the highest GWP and this was mainly due to the use phase and the fossil carbon emissions associated to the use of diesel
Therapeutic targeting of CK2 in acute and chronic leukemias
CK2 is a ubiquitously expressed, constitutively active Ser/Thr protein kinase, which is considered the most pleiotropic protein kinase in the human kinome. Such a pleiotropy explains the involvement of CK2 in many cellular events. However, its predominant roles are stimulation of cell growth and prevention of apoptosis. High levels of CK2 messenger RNA and protein are associated with CK2 pathological functions in human cancers. Over the last decade, basic and translational studies have provided evidence of CK2 as a pivotal molecule driving the growth of different blood malignancies. CK2 overexpression has been demonstrated in nearly all the types of hematological cancers, including acute and chronic leukemias, where CK2 is a key regulator of signaling networks critical for cell proliferation, survival and drug resistance. The findings that emerged from these studies suggest that CK2 could be a valuable therapeutic target in leukemias and supported the initiation of clinical trials using CK2 antagonists. In this review, we summarize the recent advances on the understanding of the signaling pathways involved in CK2 inhibition-mediated effects with a particular emphasis on the combinatorial use of CK2 inhibitors as novel therapeutic strategies for treating both acute and chronic leukemia patients
Life cycle assessment of conventional and advanced two-stage energy-from-waste technologies for methane production
This study integrates the Life Cycle Assessment (LCA) of thermal and biological technologies for municipal solid waste management within the context of renewable resource use for methane production. Five different scenarios are analysed for the UK, the main focus being on advanced gasification-plasma technology for Bio Substitute natural gas (Bio-SNG) production, anaerobic digestion and incineration. Firstly, a waste management perspective has been taken and a functional unit of 1 kg of waste to be disposed was used; secondly, according to an energy production perspective a functional unit of 1 MJ of renewable methane produced was considered. The first perspective demonstrates that when the current energy mix is used in the analysis (i.e. strongly based on fossil resources), processes with higher electric efficiency determine lower global warming potential (GWP). However, as the electricity mix in the UK becomes less carbon intensive and the natural gas mix increases the carbon intensity, processes with higher Bio-SNG yield are shown to achieve a lower global warming impact within the next 20 years. When the perspective of energy production is taken, more efficient technologies for renewable methane production give a lower GWP for both current and future energy mix. All other LCA indicators are also analysed and the hot spot of the anaerobic digestion process is performed
Therapeutic potential of targeting sphingosine kinases and sphingosine 1-phosphate in hematological malignancies
Sphingolipids, such as ceramide, sphingosine and sphingosine 1-phosphate (S1P) are bioactive molecules that have important functions in a variety of cellular processes, which include proliferation, survival, differentiation and cellular responses to stress. Sphingolipids have a major impact on the determination of cell fate by contributing to either cell survival or death. Although ceramide and sphingosine are usually considered to induce cell death, S1P promotes survival of cells. Sphingosine kinases (SPHKs) are the enzymes that catalyze the conversion of sphingosine to S1P. There are two isoforms, SPHK1 and SPHK2, which are encoded by different genes. SPHK1 has recently been implicated in contributing to cell transformation, tumor angiogenesis and metastatic spread, as well as cancer cell multidrug-resistance. More recent findings suggest that SPHK2 also has a role in cancer progression. This review is an overview of our understanding of the role of SPHKs and S1P in hematopoietic malignancies and provides information on the current status of SPHK inhibitors with respect to their therapeutic potential in the treatment of haematological cancers
Crosstalks of GSK3 signaling with the mTOR network and effects on targeted therapy of cancer
Abstract
The introduction of therapeutics targeting specific tumor-promoting oncogenic or non-oncogenic signaling pathways has revolutionized cancer treatment. Mechanistic (previously mammalian) target of rapamycin (mTOR), a highly conserved Ser/Thr kinase, is a central hub of the phosphatidylinositol 3-kinase (PI3K)/Akt/mTOR network, one of the most frequently deregulated signaling pathways in cancer, that makes it an attractive target for therapy. Numerous mTOR inhibitors have progressed to clinical trials and two of them have been officially approved as anticancer therapeutics. However, mTOR-targeting drugs have met with a very limited success in cancer patients. Frequently, the primary impediment to a successful targeted therapy in cancer is drug-resistance, either from the very beginning of the therapy (innate resistance) or after an initial response and upon repeated drug treatment (evasive or acquired resistance). Drug-resistance leads to treatment failure and relapse/progression of the disease. Resistance to mTOR inhibitors depends, among other reasons, on activation/deactivation of several signaling pathways, included those regulated by glycogen synthase kinase-3 (GSK3), a protein that targets a vast number of substrates in its repertoire, thereby orchestrating many processes that include cell proliferation and survival, metabolism, differentiation, and stemness. A detailed knowledge of the rewiring of signaling pathways triggered by exposure to mTOR inhibitors is critical to our understanding of the consequences such perturbations cause in tumors, including the emergence of drug-resistant cells. Here, we provide the reader with an updated overview of intricate circuitries that connect mTOR and GSK3 and we relate them to the efficacy (or lack of efficacy) of mTOR inhibitors in cancer cells
Experimental Analysis of the Thermal Performance of Wood Fiber Insulating Panels
During the last decades, attention to energy and environmental problems has significantly grown, along with the development of international and national policies addressing sustainability issues. In the construction sector, one of the most widespread energy efficiency strategies consists of thermal insulation of buildings thanks to external insulating panels. Among these, wood fiber is an insulating material characterized by a natural, eco-sustainable and biodegradable structure, coming from the recycling of waste wood from sawmills. The present study aimed to characterize small test building insulated with wood fiber panels from the thermal point of view, comparing the results with those of an identical, non-insulated reference test building. The experimental campaign highlighted several advantages and an excellent thermal performance provided by the eco-sustainable solution of wood fiber insulating panels: Lower values of the thermal transmittance (-57%), thus ensuring greater stability of the internal air temperature and better values in terms of attenuation (-60% in summer and -74 % in winter) and phase shift (+2 h in summer and +2.28 h in winter) compared to those obtained from the reference building. The material is also equipped with an Environmental Performance Declaration (EPD) that certifies its environmental benefits
- …